AI diagnostics and what clinicians can verify in oncology
"The more AI changes what we do … the less able we are to check it.”
By
Lisa Astor
October 1, 2026
Clinical Scorecard: AI diagnostics and what clinicians can verify in oncology
At a Glance
Category Detail
Condition Oncology
Key Mechanisms Application of AI in medical imaging to enhance diagnostic capabilities and identify features not visible to humans.
Target Population Patients undergoing diagnostic imaging in oncology.
Care Setting Clinical settings utilizing AI for diagnostic imaging.
Key Highlights
AI applications in oncology are categorized into three tiers based on their capabilities. Tier one applications are FDA-cleared tools that identify features visible to humans. Tier three applications, such as the Artera AI assay, predict treatment benefits but face challenges in verifiability. Verifiability decreases with higher-tier applications, impacting their acceptance in healthcare. AI can uncover previously unmeasured features, aiding in prognostication and treatment decisions.
Guideline-Based Recommendations
Diagnosis
Utilize tier one AI applications for straightforward feature identification.
Management
Monitor AI applications post-deployment to ensure accuracy and relevance.
Monitoring & Follow-up
Assess tier two applications through local validation and tier three applications over extended periods.
Risks
Be aware of data set drift and the potential degradation of prognostic models over time.
Patient & Prescribing Data
Patients with localized prostate cancer and other oncological conditions.
AI models can inform treatment decisions based on predictive analytics.
Clinical Best Practices
Ensure models provide raw output data and calibration for certainty. Understand model limitations and failure points before deployment. Incorporate multimodal AI inputs to enhance diagnostic accuracy.
Related Resources & Content